PHILADELPHIA, Pa., July 29 /PRNewswire-FirstCall/ -- AVVAA World Health Care Products (BULLETIN BOARD: AVVW) , a global biotechnology company offering therapeutic, natural skin and health care products, is pleased to announce results of Dr. Mark E Alden, MD’s review of the original scientific studies regarding safety and toxicity of AVVAA’s Neuroskin Products. In a comprehensive array of tests, Neuroskin, proved extremely safe. Neuroskin spray is a patented all natural product containing minerals and oils in a non- greasy, steriod-free, fast drying formula which promotes healing of irritated skin due to dermatitis, psoriasis and eczema.
Dr. Alden’s statement indicates that a recent clinical trial was completed in Germany by Prof. Dr. med. Reiner Scherer and Dr. med. Karlheinz Friedrich in March 2002 and will soon be published. “They [Scherer & Friedrich] conducted a study of 20 long-term psoriasis patients (some afflicted for decades). The length of the study was 4 weeks. Data included physician assessment, patient assessment and photographic documentation. The endpoint of the study was an assessment of the 4 cardinal symptoms of Psoriasis: erythema, scaling, skin plaques, and itching. The results showed an overall reduction of symptoms of 53%. Specifically, erythema was reduced 60%, scaling reduced 70%, skin plaques reduced 60% and itching reduced 45%. No toxicity was found. The investigators note that Neuroskin was exceptionally well tolerated. They were surprised by the “unexpected high patient compliance” to this program, a well known indicator of patient acceptance and positive benefit.
AVVAA President CEO Jack Farley said, “We are pleased to have received Dr. Alden’s review of the original scientific studies on the safety and efficacy of our core products. Dr. Alden is a highly qualified and respected individual who was recently named V.P. Research and Development for AVVAA. Dr. Alden has been working with us for several years and will now lead our research and development department along with several other prominent U.S. dermatologists and physicians. He will be responsible for researching other applications for Neuroskin, including its developing use in the treatment of both regular and radiation burns.”
Neuroskin has received the endorsement of the Bundesverband Neurodermitiskranker in Deutschland e.V., (the German Psoriasis Foundation), which is the equivalent of the National Psoriasis Foundation in North America.
About AVVAA World Health Care Products
AVVAA World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. AVVAA’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. AVVAA is poised to manufacture and market its O-T-C Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.
For more information, visit: http://www.avvaa.com/ or http://www.otcfn.com/avvw .
Contact: Investor Relations: Merle Goertz (West Coast) Geoffrey Eiten (604) 688-2349 OTC Financial Network (781) 444-6100 x613
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
AVVAA World Health Care Products
CONTACT: Merle Goertz (West Coast) of AVVAA World Health Care Products,+1-604-688-2349; or Geoffrey Eiten of OTC Financial Network, +1-781-444-6100ext. 613
Web site: http://www.avvaa.com/
